NCT00004311已完成2 期
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
National Center for Research Resources (NCRR)0 个研究点开始时间: 1999年10月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
OBJECTIVES: I. Evaluate insulin resistance in thin and obese hyperandrogenic women with polycystic ovarian disease or hyperandrogenism insulin resistance acanthosis nigricans syndrome and in thin and obese controls, using an estimation of tissue sensitivity to insulin.
II. Evaluate the effect of androgen suppression with leuprolide acetate and spironolactone on insulin secretion and resistance.
详细描述
PROTOCOL OUTLINE: Participants are treated with subcutaneous leuprolide acetate followed by oral spironolactone. Each treatment is administered daily for 6 weeks, with a 6-week washout between drugs.
Patients and controls are alternately assigned to begin treatment with leuprolide acetate or spironolactone.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 —（Child, Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics-- Polycystic ovarian disease Oligomenorrhea or amenorrhea Hirsutism Hyperandrogenism Hyperandrogenism insulin resistance acanthosis nigricans syndrome Hyperandrogenism Oligomenorrhea or amenorrhea Insulin resistance Acanthosis nigricans Hematocrit at least 30% Women with normal menstrual cycles not using oral contraception entered as controls
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Insulin Resistance in Women With ProlactinomaInsulin ResistanceHyperlipidemiaProlactinomaNCT00481299Universidade Federal do Rio de Janeiro2,004
招募中
不适用
FATLOSE trial: Fecal Administration To LOSE weight.NL-OMON23407Academic Medical CentrePO Box 22660 1100 DD Amsterdam tel: +31-20-566911120
招募中
4 期
Liraglutide Treatment in Obese Infertile PCOS WomenPCOSInfertilityObesityNCT06742710Peking University Third Hospital890
已完成
不适用
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)Polycystic Ovary SyndromeNCT00606671Hvidovre University Hospital65
已完成
不适用
Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and AccumulationPolycystic Ovarian Syndrome (PCOS)OverweightObeseInsulin ResistanceNCT02105428Mayo Clinic44